Skip to content
Tablet Allopathic

Feoza 45 mg tablet

Generic: Fezolinetant

Company: Square Pharmaceuticals PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength45 mg
PackStrip: 950.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated November 16, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Fezolinetant 45 mg tablets

Prices as listed on BestinMeds.

2 brands listed
Feoza (this medicine)95.00 taka per tablet
Fezotan95.00 taka per tablet

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Fezolinetant guide

Indications

Fezolinetant tablet is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.

Dosage and administration

Take a single 45 mg Fezolinetant tablet orally once daily with or without food. Take Fezolinetant with liquids and swallow whole. Do not cut, crush, or chew tablets. Administer Fezolinetant orally at about the same time each day. If a dose of Fezolinetant is missed or not taken at the usual time, administer the missed dose as soon as possible, unless there is less than 12 hours before the next scheduled dose. Return to the regular schedule the following day. Pediatric Use: The efficacy and safety of Fezolinetant in individuals less than 18 years of age have not been established. Geriatric Use: There have not been sufficient numbers of geriatric women involved in clinical trials utilizing Fezolinetant to determine whether those over 65 years of age differ from younger women in their response to Fezolinetant.

Side effects

Common side efects of Fezolinetant include: stomach (abdominal) pain diarrhea difculty sleeping back pain hot fashes or hot fushes Stop Fezolinetant if you have the following signs or symptoms of liver problems: nausea vomiting itching yellowing of the eyes or skin (jaundice) pale feces dark urine pain in the right upper stomach (abdomen)

Precautions and warnings

Hepatic Transaminase Elevation and Hepatotoxicity: Elevations in serum transaminase concentrations greater than 3 times the upper limit of normal (ULN) occurred in the clinical trials. Perform hepatic laboratory tests prior to initiation of Fezolinetant to evaluate for hepatic function and injury. Patient should not start Fezolinetant if the concentration of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) is equal to or exceeds 2 times the ULN or if the total bilirubin is elevated (for example, equal to or exceeds 2 times the ULN) for the evaluating laboratory. Patient should perform follow-up hepatic laboratory tests monthly for the frst 3 months, at 6 months, and 9 months after initiation of therapy.

Pregnancy and lactation

There are no data on Fezolinetant use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are no data on the presence of fezolinetant in human milk, the effects on the breastfed child, or the effects on milk production. It is not known if fezolinetant is present in human milk.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250